Cepheid's Q3 Revenues Rise 25 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its third-quarter revenues jumped 25 percent and its non-GAAP net income more than doubled on strong clinical sales.

The Sunnyvale, Calif.-based molecular diagnostics firm brought in total revenues of $70.2 million for the three months ended Sept. 30, compared to $56.1 million for the third quarter of 2010. It beat analysts' consensus estimate for revenues of $68.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.